Dublin, April 20, 2016 -- Research and Markets has announced the addition of the "Blood Collection and Processing Supplies - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
This report analyzes the worldwide markets for Blood Collection and Processing Supplies in US$ by the following Product Segments:
- Blood Administration Sets
- Blood Collection Needles
- Blood Collection Tubes & Micro Collectors
- Blood Lancets
- Blood Bags
- Blood Grouping Reagents
- Coagulation Reagents
- Hematology Reagents
- Microscopic Slides
- Slide Stainers
- Test Tube Racks
- Vials
The report profiles 121 companies including many key and niche players such as
- AdvaCare Pharmaceuticals (China)
- Beckman Coulter, Inc. (US)
- Becton, Dickinson and Company (US)
- Fresenius Kabi AG (Germany)
- Fenwal, Inc. (US)
- Grifols International S.A. (Spain)
- Haemonetics Corporation (US)
- Immucor, Inc. (US)
- JMS Co. Ltd. (Japan)
- Kawasumi Laboratories, Inc. (Japan)
- MacoPharma SA (France)
- Shanghai Transfusion Technology Co., Ltd. (China)
- Stago (France)
- Terumo Corporation (Japan)
- Terumo BCT, Inc. (US)
Key Topics Covered:
1. Industry Overview
2. Market Dynamics
3. Competitive Landscape In The Blood Processing Supplies And Equipment Market
4. Blood Collection Market
5. Blood Components & Derivatives
6. Blood Banking
7. Autologous Blood Transfusions Vis-A-Vis Allogenic Blood Transfusions
8. Autologous Transfusions: Minimizing Risk Of Blood-Borne Diseases
9. Blood Collection And Processing Supplies: An Overview
10. Product Innovations/Introductions
11. Recent Industry Activity
12. Focus On Select Players
13. Global Market Perspective
Total Companies Profiled: 121 (including Divisions/Subsidiaries 134)
- The United States (44)
- Canada (3)
- Japan (5)
- Europe (47)
- - France (3)
- - Germany (11)
- - The United Kingdom (12)
- - Italy (4)
- - Spain (1)
- - Rest of Europe (16)
- Asia-Pacific (Excluding Japan) (28)
- Latin America (1)
- Africa (4)
- Middle-East (2)
For more information visit http://www.researchandmarkets.com/research/t62l4d/blood_collection
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 



